The FDA will make the background materials, such as the meeting agenda and committee roster, available to the public no later than two business days before the meeting.
The FDA’s Vaccines and Related Biological Products Advisory Committee doesn’t make the final decision on whether to authorize a vaccine, but provides guidance to the agency following the public discussion.
Moderna submitted its application for emergency approval Nov. 30. The FDA said the amount of time before the meeting will allow the agency to thoroughly evaluate the data submitted by Moderna so it can hold a “robust” discussion. The agency will livestream the meeting on its YouTube, Facebook and Twitter pages.
More articles on pharmacy:
Moderna to file for emergency use authorization for COVID-19 vaccine
AstraZeneca may run extra COVID-19 vaccine trial amid scrutiny over results
Canada bans export of some drugs to US
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.